Skip to main content
Top
Published in: European Journal of Medical Research 1/2013

Open Access 01-12-2013 | Research

A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder

Authors: Ranlu Liu, Xiaoqiang Xie, Zhihong Zhang, Yong Xu

Published in: European Journal of Medical Research | Issue 1/2013

Login to get access

Abstract

Background

Prostate cancer (PCa) originating from the prostate base may intrude into the urinary bladder and may be misdiagnosed as bladder cancer. In this retrospective study, we reviewed the clinic data on PCa cases which were initially misdiagnosed as bladder cancer in order to identify diagnostic methods that would allow a better differential diagnosis for PCa.

Methods

Out of a total of 455 patients treated for PCa at our hospital between April 2003 and June 2011, 14 patients (3.1%) had been initially misdiagnosed as urinary bladder urothelial cell carcinoma. The clinical data on these 14 cases was retrieved and analyzed.

Results

Of the 14 patients, 11 patients were eventually diagnosed with PCa after MRI examination, and seven out of these had PCa with bladder neck invasion. Prostate needle biopsy or transurethral resection of prostate (TURP) revealed that all 14 patients had adenocarcinoma of prostate with Gleason scores ranging from 7 to 9. Nine patients received TURP for hematuria or lower urinary tract blockage. The mean follow-up was 37 months, during which six patients survived.

Conclusions

As clinical presentation and in emergency settings, prostate cancer originating from the prostate base can be confused with bladder cancer originating from the neck or the triangle region of the urinary bladder. Serum prostate specific antigen (PSA) levels and digital rectal examination, in combination with transrectal ultrasound (TRUS), MRI, and prostate needle biopsy are valuable tools for definitive differential diagnosis of the basal prostate cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61: 69–90. 10.3322/caac.20107CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61: 69–90. 10.3322/caac.20107CrossRefPubMed
3.
go back to reference Krishnan B, Truong LD: Prostatic adenocarcinoma diagnosed by urinary cytology. Am J Clin Pathol 2000, 113: 29–34. 10.1309/4T6H-549R-CAPJ-FEY0CrossRefPubMed Krishnan B, Truong LD: Prostatic adenocarcinoma diagnosed by urinary cytology. Am J Clin Pathol 2000, 113: 29–34. 10.1309/4T6H-549R-CAPJ-FEY0CrossRefPubMed
4.
go back to reference Varma M, Morgan M, Amin MB, Wozniak S, Jasani B: High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology 2003, 42: 167–172. 10.1046/j.1365-2559.2003.01560.xCrossRefPubMed Varma M, Morgan M, Amin MB, Wozniak S, Jasani B: High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology 2003, 42: 167–172. 10.1046/j.1365-2559.2003.01560.xCrossRefPubMed
5.
go back to reference Varma M, Jasani B: Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature. Histopathology 2005, 47: 1–16. 10.1111/j.1365-2559.2005.02188.xCrossRefPubMed Varma M, Jasani B: Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature. Histopathology 2005, 47: 1–16. 10.1111/j.1365-2559.2005.02188.xCrossRefPubMed
6.
go back to reference Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI: Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol 2007, 31: 1246–1255. 10.1097/PAS.0b013e31802f5d33CrossRefPubMed Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI: Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol 2007, 31: 1246–1255. 10.1097/PAS.0b013e31802f5d33CrossRefPubMed
7.
go back to reference Martinez-Pineiro JA, Muntanola P, Martin MG, Hidalgo L: Fluorescence urinary cytology in bladder cancer. Eur Urol 1977, 3: 142–144.PubMed Martinez-Pineiro JA, Muntanola P, Martin MG, Hidalgo L: Fluorescence urinary cytology in bladder cancer. Eur Urol 1977, 3: 142–144.PubMed
8.
go back to reference Raab SS, Lenel JC, Cohen MB: Low-grade transitional cell carcinoma of the bladder. cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 1994, 74: 1621–1626. 10.1002/1097-0142(19940901)74:5<1621::AID-CNCR2820740521>3.0.CO;2-ECrossRefPubMed Raab SS, Lenel JC, Cohen MB: Low-grade transitional cell carcinoma of the bladder. cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 1994, 74: 1621–1626. 10.1002/1097-0142(19940901)74:5<1621::AID-CNCR2820740521>3.0.CO;2-ECrossRefPubMed
9.
go back to reference Romero FR, De Castro MG, Andriolo Júnior A, De Meneses AH, Fernandes RC, Perez MD: Coexistence of prostate neoplasia in patients undergoing radical cystoprostatectomy due to vesical neoplasia. Int Braz J Urol 2004, 30(4):296–301. 10.1590/S1677-55382004000400005CrossRefPubMed Romero FR, De Castro MG, Andriolo Júnior A, De Meneses AH, Fernandes RC, Perez MD: Coexistence of prostate neoplasia in patients undergoing radical cystoprostatectomy due to vesical neoplasia. Int Braz J Urol 2004, 30(4):296–301. 10.1590/S1677-55382004000400005CrossRefPubMed
10.
go back to reference Mazzucchelli R, Barbisan F, Santinelli A, Scarpelli M, Galosi AB, Lopez-Beltran A, Cheng L, Kirkali Z, Montironi R: Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer. Urology 2009, 74(2):385–390. 10.1016/j.urology.2009.03.010CrossRefPubMed Mazzucchelli R, Barbisan F, Santinelli A, Scarpelli M, Galosi AB, Lopez-Beltran A, Cheng L, Kirkali Z, Montironi R: Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer. Urology 2009, 74(2):385–390. 10.1016/j.urology.2009.03.010CrossRefPubMed
11.
go back to reference Tang P, Chen H, Uhlman M, Lin YR, Deng XR, Wang B, Yang WJ, Xie KJ: A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer. Asian J Androl 2013, 15(1):129–133. 10.1038/aja.2012.111PubMedCentralCrossRefPubMed Tang P, Chen H, Uhlman M, Lin YR, Deng XR, Wang B, Yang WJ, Xie KJ: A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer. Asian J Androl 2013, 15(1):129–133. 10.1038/aja.2012.111PubMedCentralCrossRefPubMed
12.
go back to reference Hricak H: MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 2005, 78(2):S103-S111.CrossRefPubMed Hricak H: MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 2005, 78(2):S103-S111.CrossRefPubMed
13.
go back to reference Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, et al.: Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression. Clin Cancer Res 2011, 17: 7673–7683. 10.1158/1078-0432.CCR-11-2048CrossRefPubMed Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, et al.: Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression. Clin Cancer Res 2011, 17: 7673–7683. 10.1158/1078-0432.CCR-11-2048CrossRefPubMed
14.
go back to reference Matlaga BR, Eskew LA, McCullough DL: Prostate biopsy: indications and technique. J Urol 2003, 169: 12–19. 10.1016/S0022-5347(05)64024-4CrossRefPubMed Matlaga BR, Eskew LA, McCullough DL: Prostate biopsy: indications and technique. J Urol 2003, 169: 12–19. 10.1016/S0022-5347(05)64024-4CrossRefPubMed
15.
go back to reference Ekwueme K, Simpson H, Zakhour H, Parr NJ: Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy. BJU Int 2013, 111(8):E365-E373. 10.1111/bju.12134CrossRefPubMed Ekwueme K, Simpson H, Zakhour H, Parr NJ: Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy. BJU Int 2013, 111(8):E365-E373. 10.1111/bju.12134CrossRefPubMed
16.
go back to reference McNeal JE, Redwine EA, Freiha FS, Stamey TA: Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988, 12: 897–906. 10.1097/00000478-198812000-00001CrossRefPubMed McNeal JE, Redwine EA, Freiha FS, Stamey TA: Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988, 12: 897–906. 10.1097/00000478-198812000-00001CrossRefPubMed
Metadata
Title
A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder
Authors
Ranlu Liu
Xiaoqiang Xie
Zhihong Zhang
Yong Xu
Publication date
01-12-2013
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2013
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/2047-783X-18-36

Other articles of this Issue 1/2013

European Journal of Medical Research 1/2013 Go to the issue